Disseminated intravascular coagulation

From Food & Medicine Encyclopedia

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Disseminated intravascular coagulation
Micrograph showing acute thrombotic microangiopathy
Synonyms Consumptive coagulopathy, defibrination syndrome
Pronounce N/A
Specialty N/A
Symptoms Bleeding, bruising, thrombosis, organ failure
Complications Shock (circulatory), multi-organ failure
Onset Acute or chronic
Duration Variable
Types N/A
Causes Sepsis, trauma, cancer, obstetric complications, snake bites
Risks Infection, inflammation, malignancy
Diagnosis Blood tests showing low platelet count, low fibrinogen, elevated D-dimer, prolonged prothrombin time
Differential diagnosis Thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, liver disease
Prevention N/A
Treatment Treat underlying cause, supportive care, blood product transfusion
Medication N/A
Prognosis Variable, depends on underlying cause and severity
Frequency Common in critically ill patients
Deaths N/A


Disseminated intravascular coagulation Disseminated intravascular coagulation (DIC) is a complex systemic disorder characterized by both widespread clotting and bleeding. It typically arises as a secondary condition in response to an underlying disease or trauma, disrupting the balance between the body's clotting and anti-clotting mechanisms.

DIC With Microangiopathic Hemolytic Anemia

Pathophysiology[edit]

In DIC, the normal hemostatic balance is disrupted, leading to excessive clotting and, paradoxically, a risk of severe bleeding. The pathophysiological process begins with the widespread activation of the coagulation cascade, leading to the formation of microthrombi in the blood vessels. This over-activation depletes the body's reserves of clotting factors and platelets, leading to a coagulopathic state that can result in hemorrhage.

Causes and Risk Factors[edit]

DIC can be triggered by a wide range of conditions, most commonly sepsis Sepsis, severe trauma, malignancies, obstetric complications, and severe burns. Some individuals may be at a higher risk for developing DIC, including those with severe infections, extensive tissue damage, or certain types of cancer.

Clinical Manifestations[edit]

The signs and symptoms of DIC can vary widely, depending on the underlying cause and the balance between clotting and bleeding. Symptoms may include bleeding from multiple sites, thrombosis, end-organ damage, and in severe cases, shock or multiorgan failure.

Diagnosis[edit]

The diagnosis of DIC is made through a combination of clinical findings and laboratory tests. Lab tests typically show prolonged clotting times, low platelet counts, increased levels of fibrin degradation products, and decreased levels of clotting factors.

Management and Treatment[edit]

Management of DIC primarily involves treating the underlying cause. Supportive care, such as transfusion of blood products, may be necessary. In some cases, drugs that inhibit clot formation, such as heparin, may be used, although this is controversial and depends on the patient's individual clinical situation.

Prognosis[edit]

The prognosis of DIC depends largely on the underlying cause and the patient's overall clinical condition. If the triggering condition can be effectively treated, the DIC often resolves. However, in severe cases or when the underlying cause cannot be controlled, DIC can contribute to significant morbidity and mortality.

References[edit]

  • Wada, H., Thachil, J., Di Nisio, M., et al. (2013). "Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines". Journal of Thrombosis and Haemostasis.
  • Levi, M., Toh, CH., Thachil, J., Watson, HG. (2009). "Guidelines for the diagnosis and management of disseminated intravascular coagulation". British Journal of Haematology.
  • Levi, M. (2018). "Disseminated Intravascular Coagulation". Critical Care Medicine.

External Links[edit]

  • Mayo Clinic - Disseminated intravascular coagulation (DIC)
  • MedlinePlus - Disseminated intravascular coagulation
This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.